Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy
L Giovanella, L Ceriani, A Ghelfo… - Clinical …, 2007 - Wiley Online Library
Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
L Giovanella, L Ceriani, A Ghelfo, M Maffioli… - Clinical …, 2007 - sonar.ch
AIM We retrospectively evaluated the incidence of undetectable or reduced preoperative
serum Tg in a group of 436 patients affected by DTC. Additionally, we evaluated the role of …
serum Tg in a group of 436 patients affected by DTC. Additionally, we evaluated the role of …
[PDF][PDF] Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy
L Giovanella, L Ceriani, A Ghelfo, M Maffioli… - Clinical …, 2007 - researchgate.net
Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
L Giovanella, L Ceriani, A Ghelfo, M Maffioli… - Clinical …, 2007 - europepmc.org
Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
[引用][C] Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy
L GIOVANELLA, L CERIANI, A GHELFO… - Clinical …, 2007 - pascal-francis.inist.fr
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma :
incidence, causes and management strategy CNRS Inist Pascal-Francis CNRS Pascal and …
incidence, causes and management strategy CNRS Inist Pascal-Francis CNRS Pascal and …
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
L Giovanella, L Ceriani, A Ghelfo… - Clinical …, 2007 - search.ebscohost.com
Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
L Giovanella, L Ceriani, A Ghelfo, M Maffioli… - Clinical …, 2007 - folia.unifr.ch
AIM We retrospectively evaluated the incidence of undetectable or reduced preoperative
serum Tg in a group of 436 patients affected by DTC. Additionally, we evaluated the role of …
serum Tg in a group of 436 patients affected by DTC. Additionally, we evaluated the role of …
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy
L Giovanella, L Ceriani, A Ghelfo… - Clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …